NitrilesPrimary MyelofibrosisPyrazoles
Dr. Roger M. Lyons, MD
NPI1508838285PAC ID2860459302
- Medicare services, 2023
- 420
- Part D claims, 2022
- 24
- Publications
- 79
- Clinical trials
- 18
- MIPS score, 2024
- 85
- Practice address
- 5206 Research Dr, San Antonio, TX 78240-5251
- Practice phone
- Call (210) 595-5300
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Texas Oncology - San Antonio (Research Dr)
Multi-specialty group site · San Antonio, Texas
Find Dr. Lyons' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Roger M. Lyons is a hematology (internal medicine) physician in San Antonio, Texas
Dr. Lyons practices at Texas Oncology - San Antonio (Research Dr) in San Antonio, Texas.
Dr. Lyons' NPI, 1508838285, was assigned on February 6, 2006. Dr. Lyons graduated from University of Manitoba in 1967. Dr. Lyons holds Texas license E3811.
NPI and contact details
- NPI
- 1508838285NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2860459302
- NPI enumeration date
- February 6, 2006
- NPI status
- Active
- Practice phone
- (210) 595-5300
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 85
- Medical school graduation
- 1967
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Roger M. Lyons practices at Texas Oncology - San Antonio (Research Dr) in San Antonio, Texas
Dr. Lyons' primary practice is Texas Oncology - San Antonio (Research Dr), at 5206 Research Dr, San Antonio, TX 78240-5251. The practice phone is (210) 595-5300.
- Texas Oncology - San Antonio (Research Dr)5206 Research Dr, San Antonio, TX 78240-5251Phone(210) 595-5300
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Roger M. Lyons is affiliated with 6 sites of care and 4 medical groups
Dr. Lyons' primary practice is Texas Oncology - San Antonio (Research Dr) in San Antonio, Texas. The medical group on file is Texas Oncology. Dmand AI also links Dr. Lyons to 3 more group practices and clinics, 3 medical groups and 2 physician offices, each named with a free account.
Texas Oncology - San Antonio (Research Dr)Primary
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dmand AI tracks the EHR system at Dr. Roger M. Lyons' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lyons practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Texas Oncology - San Antonio (Research Dr) | Available with a free account |
| +5 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Lyons practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Roger M. Lyons is one of 62 hematology (internal medicine) physicians in Texas
Internal medicine is Dr. Lyons' primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Lyons is board certified in hematology by the American Board of Internal Medicine. Dr. Lyons is licensed in Texas.
Specialties and state licenses
- Hematology (internal medicine), TexasPrimary
Clinical focus
Dmand AI lists chronic leukemia, lymphoma and multiple myeloma among the conditions Dr. Lyons treats.
Hematology (internal medicine) physicians near Dr. Lyons
Counts of hematology (internal medicine) physicians with a Dmand AI profile, by place and practice. Each opens the list.
62hematology (internal medicine) physicians in Texas
9hematology (internal medicine) physicians in San Antonio
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Roger M. Lyons billed Medicare for 420 services in 2023
CMS data shows 420 Medicare services from Dr. Lyons across 2 procedure codes in 2023. Medicare paid $4,201 for them. Every service was in an office.
Medicare services, 2023420
Paid by Medicare$4,201
Procedure codes2
Dr. Lyons' Medicare services by type, 2022 to 2023
- 2022
- 2023
- Lab and pathology
- 2022: 2,1702023: 42081%
- Other services
- 2022: 412023: 0100%
- Surgery
- 2022: 702023: 0100%
- Office and hospital visits
- 2022: 152023: 0100%
Dr. Lyons compared with the Texas median for hematology (internal medicine) physicians, 2023
- Dr. Lyons
- Texas median
- Medicare services
- 420vs 35120% above
- Part D claims
- 24vs 10677% below
Medians across 58 hematology (internal medicine) physicians in Texas with Dmand AI profiles that report each measure.
Dr. Lyons' most billed Medicare procedure codes, 2023
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Lyons?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lyons and other hematology (internal medicine) physicians in Texas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Roger M. Lyons' patients have a median age of 73
Across all payers, Dmand AI patient panel data puts Dr. Lyons' median patient age at 73, with 29% women.
Dr. Lyons' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women29%
- Men71%
Source: Dmand AI Patient Panel Data
Dr. Roger M. Lyons wrote 24 Medicare Part D claims in 2022
In 2022, Dr. Lyons wrote 24 Medicare Part D claims. They cover 2 drugs, with $53,964 in total drug cost. In 2021, CMS named 214 claims across 9 drugs.
Part D claims, 202224
Drugs named by CMS2
Total drug cost$53,964
Dr. Lyons' most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 2142022: 2489%
Drugs named by CMS: 2 in 2022, 9 in 2021.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
Dr. Roger M. Lyons scored 85 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Lyons for performance year 2024, reported through an alternative payment model (APM).
Dr. Lyons' MIPS scores, performance year 2024
- 85of 100Final score
- 67.5of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematology (internal medicine) physicians like Dr. Lyons by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Roger M. Lyons has 79 publications on record
Dmand AI links 79 papers to Dr. Lyons, published from 2008 to 2025. 2017 was the busiest year, with 5. The most frequent topics are Myelodysplastic Syndromes, Recombinant Fusion Proteins and Double-Blind Method. Dr. Lyons has published most often in Blood. Dr. Lyons' most frequent co-authors are Ruben Anthony Mesa, MD, Ronald Leo Paquette, MD and Mikkael A. Sekeres, MD.
Papers79
Years published2008 to 2025
Dr. Lyons' papers by year, 2016 to 2025
Topics Dr. Lyons writes about most
- Myelodysplastic Syndromes
- Recombinant Fusion Proteins
- Double-Blind Method
- Multiple Myeloma
- Receptors, Fc
- Thrombopoietin
- Anticoagulants
- Blood Platelets
Dr. Lyons' most frequent co-authors
- Ruben Anthony Mesa, MD6 shared papers
- Ronald Leo Paquette, MD6 shared papers
- Mikkael A. Sekeres, MD6 shared papers
Recent publications by Dr. Lyons
HydroxyureaPolycythemia Vera
Amino Acid Transport System ASCHematologic NeoplasmsImmunoconjugates
BortezomibMolecular Targeted TherapyMultiple Myeloma
Clin Lymphoma Myeloma Leuk
HydroxyureaPrimary MyelofibrosisThrombocythemia, Essential
See who Dr. Lyons researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lyons works with, so you can find a warm path to the right hematology (internal medicine) physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Roger M. Lyons has worked on 18 clinical trials
Dmand AI links Dr. Lyons to 18 clinical trials, 10 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Multiple Myeloma, Myelodysplastic Syndromes and Blood Protein Disorders. Telik sponsors the most, 2.
Clinical trials with Dr. Lyons by phase
- 2Phase 1: 2 trials
- 2Phase 1/2: 2 trials
- 10Phase 2: 10 trials
- 2Phase 3: 2 trials
- 1Phase 4: 1 trial
Conditions in Dr. Lyons' trials
- Multiple Myeloma
- Myelodysplastic Syndromes
- Blood Protein Disorders
- Bone Marrow Diseases
- Anemia, Refractory, with Excess of Blasts
Investigators on the most trials with Dr. Lyons
- Sudhir Manda, MD3 shared trials
- David Jacob Andorsky, MD2 shared trials
- Alberto Bessudo, MD2 shared trials
Recent clinical trials with Dr. Lyons
Multiple MyelomaBlood Protein DisordersDexamethasoneIxazomibLenalidomide
A Phase II Trial of Daratumumab, Lenalidomide and Dexamethasone (DRd) in Combination With Selinexor for Patients With Newly Diagnosed Multiple Myeloma (opens in a new tab)
Active, not recruitingPhase 2
Multiple MyelomaBlood Protein DisordersDaratumumabLenalidomideSelinexor
Leukemia, Myelomonocytic, ChronicMyelodysplastic-Myeloproliferative DiseasesAlvocidib Plus Decitabine (during dose escalation only) or Azacitidine
Lymphoma, T-Cell, PeripheralLymphoma, Large-Cell, AnaplasticBrentuximab vedotin
Myelodysplastic SyndromesBone Marrow DiseasesAzacitidineDecitabineINQOVI (oral decitabine)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Roger M. Lyons received $75,437 in industry payments from 2016 to 2025
CMS Open Payments shows 1,120 general payments to Dr. Lyons from 63 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 54% of the total. Incyte Corporation paid the most, $25,171. It also lists 37 research payments totaling $262,814 from 2016 to 2023.
General payments to Dr. Lyons by program year, 2016 to 2025
General payments to Dr. Lyons by kind, 2016 to 2025
$75.4Kin total
- Consulting fees$40,47454%
- Food and beverage$20,98928%
- Speaker and faculty fees$10,87614%
- Travel and lodging$2,6964%
- Education$4021%
Companies that paid Dr. Lyons the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Roger M. Lyons has 6 awards and honors on record
Dmand AI lists 6 awards for Dr. Lyons, most recently America's Top Doctors in 2014.
Awards and honors for Dr. Lyons
- 2014
- America's Top Doctors
- 2013
- America's Top Doctors for Cancer
- Top Doctors:SE Texas
- 2012
- Super Doc
- Undated
- Checkbook Top Doc
- CMS Stage 1 2012
Source: Dmand AI Professional Profile Data
Dr. Roger M. Lyons graduated from University of Manitoba
Dr. Lyons graduated from University of Manitoba in 1967.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
Source: Dmand AI Professional Profile Data
Dr. Roger M. Lyons accepts plans from 21 insurance carriers
Dr. Lyons is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.
- Aetna
- Elevance
- Blue Cross Blue Shield of Michigan
- United Healthcare
- Cigna
- HCSC
- Humana
- Alliant Health Plans
- +13 more carriersWith a free account
Plan types Dr. Lyons accepts, by number of carriers
- PPO14
- HMO12
- Medicare9
- POS6
- EPO4
Source: Dmand AI Insurance Network Data
Sources for Dr. Roger M. Lyons's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Roger M. Lyons
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Roger M. Lyons' NPI number?
Dr. Roger M. Lyons' NPI number is 1508838285. It was assigned on February 6, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Roger M. Lyons?
Dr. Roger M. Lyons is a hematology (internal medicine) physician in San Antonio, Texas. The primary specialty in the NPI Registry is Hematology (Internal Medicine) Physician (taxonomy code 207RH0000X).
Where does Dr. Roger M. Lyons practice?
Dr. Lyons practices at 5206 Research Dr, San Antonio, TX 78240-5251. Dr. Lyons' primary practice is Texas Oncology - San Antonio (Research Dr) in San Antonio, Texas. Dmand AI also links Dr. Lyons to 3 group practices and clinics, 3 medical groups and 2 physician offices.
What is Dr. Roger M. Lyons' office phone number?
The practice phone on file for Dr. Lyons is (210) 595-5300.
What is Dr. Roger M. Lyons' medical license number?
Dr. Lyons holds Texas license E3811.
What medical group is Dr. Roger M. Lyons part of?
Dr. Lyons is linked to Texas Oncology. Dmand AI links Dr. Lyons to 3 more medical groups.
Does Dr. Roger M. Lyons accept Medicare?
Yes. CMS data shows Dr. Lyons billed Medicare for 420 services in 2023.
What is Dr. Roger M. Lyons' MIPS score?
Dr. Lyons' MIPS final score for performance year 2024 is 85 out of 100, reported through an alternative payment model (APM).
Is Dr. Roger M. Lyons board certified?
Yes. Dr. Lyons is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Roger M. Lyons bill to Medicare?
In 2023, Dr. Lyons' most billed Medicare services were lab and pathology test (84165) and lab and pathology test (86334).
Show 7 more questionsShow fewer questions
Where did Dr. Roger M. Lyons go to medical school?
Dr. Lyons graduated from University of Manitoba in 1967.
What drugs does Dr. Roger M. Lyons prescribe most?
In 2022 Medicare Part D data, Dr. Lyons' most prescribed drugs by claims were Octagam and Xarelto.
Has Dr. Roger M. Lyons received payments from drug or device companies?
CMS Open Payments shows $75,437 in general payments to Dr. Lyons from 63 companies from 2016 to 2025. The largest total came from Incyte Corporation.
How long has Dr. Roger M. Lyons been practicing?
Dr. Lyons graduated from medical school in 1967, 59 years ago.
Does Dr. Roger M. Lyons do research?
Dmand AI links 79 publications to Dr. Lyons, published from 2008 to 2025. Dr. Lyons has worked on 18 clinical trials.
Who does Dr. Roger M. Lyons publish with?
Dr. Lyons' most frequent co-authors are Ruben Anthony Mesa, MD (6 shared papers), Ronald Leo Paquette, MD (6 shared papers) and Mikkael A. Sekeres, MD (6 shared papers).
What insurance does Dr. Roger M. Lyons accept?
Dr. Lyons is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.
Selling to internal medicine practices?
See hematology (internal medicine) physicians in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card